The Signal Directory
Filter by specialty and by channel. If you want the ophthalmologists on Instagram or the nurses on LinkedIn, they are two clicks away.
Looking for founders and investors instead? Open the executive directory.
Professor of Medicine, Mayo Clinic
He offers deep analysis of multiple myeloma research, critical commentary on global pharmaceutical pricing policies, and evidence-based critiques of contemporary clinical trial designs.
Myeloma / Drug Pricing / Clinical Trials
Best for: Hematologists, clinical trialists, and health policy analysts.
Director of Medical Oncology, Rhode Island Hospital
Follow for perspectives on gynecologic cancer care, the integration of social media in medicine, and the role of digital communication in improving oncology patient care.
Gynecologic Oncology / Digital Health / Patient Communication
Best for: Oncology clinicians interested in digital patient engagement.
Director of Gastrointestinal Oncology, Intermountain Health
He shares unique perspectives as both a practicing gastrointestinal oncologist and a patient with a hereditary tumor syndrome, emphasizing compassionate care and clinical insights.
Gastrointestinal Oncology / Patient Advocacy / Medical Humanities
Best for: GI oncologists, patient advocates, and medical students.
Director of Genitourinary Oncology, Dana-Farber Cancer Institute
Provides immediate, detailed coverage of genitourinary cancer clinical trial results, immunotherapeutic breakthroughs, and global oncology meeting updates directly from a lead investigator.
GU Oncology / Immunotherapy / Clinical Trials
Best for: Genitourinary oncologists and medical researchers.
Associate Professor of Medical Oncology, City of Hope
Offers rigorous, independent analysis of clinical trials in lung cancer alongside regular discussions on digital health, oncology education, and oncology podcasts.
Thoracic Oncology / Clinical Trials / Digital Health
Best for: Thoracic oncology specialists and healthcare podcasters.
Associate Professor of Oncology, Queen's University
Promotes the "cancer groundshot" philosophy, highlighting cost-effective, evidence-based global oncology practices and critical assessments of newly approved high-cost cancer therapies.
Global Oncology / Evidence-Based Medicine / Cancer Policy
Best for: Global health advocates and health economists.
Associate Professor of Medicine, University of Illinois Chicago
Provides valuable commentary on gastrointestinal oncology, healthcare leadership, gender equity in medicine, and the strategic use of social media in clinical practice.
GI Oncology / Healthcare Leadership / Digital Media
Best for: Clinicians seeking professional development and oncology updates.
Associate Professor of Oncology, Johns Hopkins Medicine
Readers gain expert insight into breast cancer clinical trial design, FDA regulatory processes, and oncology medical education from a leader spanning academia and federal regulation.
Clinical Trials / Breast Cancer / Medical Education
Best for: Oncologists, clinical researchers, and biotech developers.
Chief of Early Phase Drug Development, Sarah Cannon Research Institute
Shares real-time updates and authoritative analysis on early-phase clinical trials, precision medicine, genomics, and next-generation targeted therapies in oncology.
Precision Oncology / Clinical Trials / Drug Development
Best for: Precision oncology researchers and clinical trialists.
Associate Director of Cancer Care Equity, Dana-Farber Cancer Institute
Delivers clinical updates in thoracic oncology alongside practical advice on fostering diversity, equity, and inclusion within modern medical education and clinical research environments.
Thoracic Oncology / Health Equity / Medical Education
Best for: Educators, thoracic oncologists, and equity advocates.
Medical oncologist, Ochsner MD Anderson Cancer Center
Follow his work on cancer care and real-world evidence, including research into multi-cancer early detection testing.
Oncology / Cancer screening / Clinical research
Best for: Oncology and diagnostics readers
Showing 11 of 362 people. Listings are editorial, not paid, and nobody pays to appear here.
